Bioactive Compound Details

BioIDbio3516
NameLONDAMOCITINIB
ChEMBL IDCHEMBL4447181
Molecular FormulaC28H31F2N7O4S
Molecular Weight599.66
Molecular Weight (Monoisotopic)599.2126
TypeSmall molecule
Max PhasePhase 2
Target IDTar18
Target NameSerine/threonine-protein kinase cot (COT)
SynonymsLONDAMOCITINIB
SmilesCOC[C@H](C(=O)Nc1cccc2c(-c3nc(Nc4cccc(S(C)(=O)=O)c4F)ncc3F)c[nH]c12)N1CCN(C)CC1
InchiInChI=1S/C28H31F2N7O4S/c1-36-10-12-37(13-11-36)22(16-41-2)27(38)33-21-8-4-6-17-18(14-31-26(17)21)25-19(29)15-32-28(35-25)34-20-7-5-9-23(24(20)30)42(3,39)40/h4-9,14-15,22,31H,10-13,16H2,1-3H3,(H,33,38)(H,32,34,35)/t22-/m1/s1
Inchi KeyJNUZADQZHYFJGW-JOCHJYFZSA-N
Molecular SpeciesNEUTRAL
Targets8.0
Bioactivities53.0
Np Likeness Score-1.21
Records Key['17; Ex 35', 'LONDAMOCITINIB', '16; AZD4604']
Records Name['(2R)-N-(3-(5-fluoro-2-(2-fluoro-3-(methylsulfonyl)phenylamino)pyrimidin-4-yl)-1H-indol-7-yl)-3-methoxy-2-(4-methylpiperazin-1-yl)propanamide', 'LONDAMOCITINIB', '(2R)-N-(3-{5-fluoro-2-[2-fluoro-3-(methanesulfonyl)anilino]-pyrimidin-4-yl}-1H-indol-7-yl)-3-methoxy-2-(4-methylpiperazin-1-yl)propanamide']
Withdrawn FlagFalse
Orphan0

Molecular Structure

2D Molecular Structure